{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:22:21Z","timestamp":1794547341291,"version":"4.9.1"},"reference-count":30,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX2025028"],"award-info":[{"award-number":["BX2025028"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["82373811"],"award-info":[{"award-number":["82373811"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["82504683"],"award-info":[{"award-number":["82504683"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["82574333"],"award-info":[{"award-number":["82574333"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Reactive oxygen species (ROS) are significantly elevated in tumor cells, providing an intrinsic trigger for selective drug activation and tumor-specific therapy. However, commonly used ROS-responsive linkers, such as thioketals and boronates, often suffer from limited sensitivity or poor physiological stability, and the development of new ROS-responsive motifs remains scarce. Herein, we develop a hydrazide-derived diazaborine (DAB) scaffold and establish it as a general ROS-responsive linker for small-molecule prodrugs, combining physiological stability with efficient ROS responsiveness. Based on this platform, we construct a DAB-derived ROS-responsive copper complex small-molecule prodrug, DDABD@Cu, for tumor-specific therapy. DDABD@Cu integrates a DAB-caged diethyldithiocarbamate (DTC) moiety with an inert copper donor, in which the DAB group effectively blocks the copper-chelating activity of DTC, enabling inert co-delivery of both components. Upon ROS activation, DTC is released to initiate copper transfer, generating cytotoxic Cu(DTC)2 in situ to induce proteotoxic stress via ubiquitinated protein accumulation while concomitantly producing quinone methide (QM) to deplete glutathione (GSH) and amplify oxidative stress. This cascade improves antitumor efficacy against non-small cell lung cancer while limiting off-target toxicity. Overall, this work provides a feasible strategy for designing ROS-responsive and copper complex prodrugs.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00776","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:34:56Z","timestamp":1788327296000},"page":"5090-5101","source":"Crossref","is-referenced-by-count":0,"title":["A Diazaborine-Based ROS Switch Enables Copper Transfer for Tumor-Specific Prodrug Activation and Therapy"],"prefix":"10.1021","volume":"23","author":[{"given":"Zeqian","family":"Huang","sequence":"first","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Ding","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Lin","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghan","family":"Wang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-7483","authenticated-orcid":true,"given":"Chunshun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, People\u2019s Republic of China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"18","key":"2026101311065201200_cit1","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"issue":"2","key":"2026101311065201200_cit2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"2026101311065201200_cit3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"2026101311065201200_cit4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"2026101311065201200_cit5","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1016\/j.apsb.2024.10.015","article-title":"Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer","volume":"14","author":"Hu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"2026101311065201200_cit6","doi-asserted-by":"publisher","first-page":"111335","DOI":"10.1016\/j.cclet.2025.111335","article-title":"ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade","volume":"37","author":"Han","year":"2026","journal-title":"Chin. Chem. Lett."},{"issue":"3","key":"2026101311065201200_cit7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.7150\/thno.121977","article-title":"Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy","volume":"16","author":"Xing","year":"2026","journal-title":"Theranostics"},{"issue":"5","key":"2026101311065201200_cit8","doi-asserted-by":"publisher","first-page":"111350","DOI":"10.1016\/j.cclet.2025.111350","article-title":"Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel","volume":"37","author":"Li","year":"2026","journal-title":"Chin. Chem. Lett."},{"issue":"5","key":"2026101311065201200_cit9","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1021\/acs.jmedchem.5c02897","article-title":"A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma","volume":"69","author":"Li","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026101311065201200_cit10","doi-asserted-by":"publisher","first-page":"113905","DOI":"10.1016\/j.jconrel.2025.113905","article-title":"Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer","volume":"384","author":"Liu","year":"2025","journal-title":"J. Contr. Release"},{"issue":"1","key":"2026101311065201200_cit11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/acs.jmedchem.0c01704","article-title":"Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"28","key":"2026101311065201200_cit12","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202523215","article-title":"An In Situ Self-Responsive Nano-Prodrug to Enable Tumor Chemo-Metalloimmunotherapy","volume":"36","author":"Yao","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"2026101311065201200_cit13","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202513250","article-title":"Self-Immolative Activatable Nanoassembly toward Immuno-Photodynamic Therapy in TME","volume":"36","author":"Li","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"32","key":"2026101311065201200_cit14","doi-asserted-by":"publisher","first-page":"41960","DOI":"10.1021\/acsami.4c10175","article-title":"Triterpene-Based Prodrug for Self-Boosted Drug Release and Targeted Oral Squamous Cell Carcinoma Chemotherapy","volume":"16","author":"Zhong","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101311065201200_cit15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.actbio.2020.03.027","article-title":"Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy","volume":"108","author":"Kim","year":"2020","journal-title":"Acta Biomater."},{"issue":"2","key":"2026101311065201200_cit16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/acsmaterialslett.5c01379","article-title":"A Tumor-Activatable Sorafenib Prodrug for Alleviating Hypoxia and Enhancing Hepatocellular Carcinoma Therapy","volume":"8","author":"Zhang","year":"2026","journal-title":"ACS Mater. Lett."},{"key":"2026101311065201200_cit17","doi-asserted-by":"publisher","first-page":"114608","DOI":"10.1016\/j.jconrel.2026.114608","article-title":"Near-infrared light-switchable unlocking of tumour-specific prodrug nanosystem for synergistic enhancement of reactive nitrogen species-based therapy","volume":"393","author":"Wang","year":"2026","journal-title":"J. Contr. Release"},{"issue":"1","key":"2026101311065201200_cit18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12943-025-02404-9","article-title":"Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment","volume":"24","author":"Du","year":"2025","journal-title":"Mol. Cancer"},{"key":"2026101311065201200_cit19","doi-asserted-by":"publisher","first-page":"123677","DOI":"10.1016\/j.biomaterials.2025.123677","article-title":"ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer","volume":"326","author":"Geng","year":"2026","journal-title":"Biomaterials"},{"issue":"10","key":"2026101311065201200_cit20","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1021\/acs.jmedchem.4c00459","article-title":"Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026101311065201200_cit21","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1021\/acs.accounts.9b00292","article-title":"The Chemistry of Boronic Acids in Nanomaterials for Drug Delivery","volume":"52","author":"Stubelius","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"5","key":"2026101311065201200_cit22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1039\/d0sc05009a","article-title":"Boronic acid based dynamic click chemistry: recent advances and emergent applications","volume":"12","author":"Chatterjee","year":"2020","journal-title":"Chem. Sci."},{"issue":"2","key":"2026101311065201200_cit23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/jacs.6b11115","article-title":"Fast Diazaborine Formation of Semicarbazide Enables Facile Labeling of Bacterial Pathogens","volume":"139","author":"Bandyopadhyay","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"93","key":"2026101311065201200_cit24","doi-asserted-by":"publisher","first-page":"12532","DOI":"10.1039\/c7cc07389e","article-title":"Fluorogenic diazaborine formation of semicarbazide with designed coumarin derivatives","volume":"53","author":"Cambray","year":"2017","journal-title":"Chem. Commun."},{"issue":"49","key":"2026101311065201200_cit25","doi-asserted-by":"publisher","first-page":"25914","DOI":"10.1002\/anie.202109835","article-title":"Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates","volume":"60","author":"Antonio","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"2026101311065201200_cit26","doi-asserted-by":"publisher","first-page":"125148","DOI":"10.1016\/j.carbpol.2026.125148","article-title":"Hyaluronic acid-based reactive oxygen species responsive nanocomposite hydrogel for sequential drug delivery and effective prevention of postoperative abdominal adhesions","volume":"381","author":"Gong","year":"2026","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"2026101311065201200_cit27","doi-asserted-by":"publisher","first-page":"108765","DOI":"10.1016\/j.cclet.2023.108765","article-title":"Combination losartan with hyaluronic acid modified diethyldithiocarbamate loaded hollow copper sulfide nanoparticles for the treatment of breast cancer and metastasis","volume":"35","author":"Hu","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"2026101311065201200_cit28","doi-asserted-by":"publisher","first-page":"114904","DOI":"10.1016\/j.jconrel.2026.114904","article-title":"A copper-based ascorbic acid-activatable gel for postoperative glioblastoma therapy","volume":"394","author":"Liu","year":"2026","journal-title":"J. Contr. Release"},{"issue":"1","key":"2026101311065201200_cit29","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1038\/s41467-024-47549-1","article-title":"Alkyne-tagged SERS nanoprobe for understanding Cu(+) and Cu(2+) conversion in cuproptosis processes","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"24","key":"2026101311065201200_cit30","doi-asserted-by":"publisher","first-page":"16221","DOI":"10.1021\/acs.analchem.0c04068","article-title":"Copolymer-Based Fluorescence Nanosensor for In Situ Imaging of Homocysteine in the Liver and Kidney of Diabetic Mice","volume":"92","author":"Zhang","year":"2020","journal-title":"Anal. Chem."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00776","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5090\/67627815\/mp6c00776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5090\/67627815\/mp6c00776.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:20:33Z","timestamp":1794543633000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/5090\/5351540\/A-Diazaborine-Based-ROS-Switch-Enables-Copper"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00776","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00776.s002","asserted-by":"subject"}]},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}